Discrimination of functionally heterogeneous receptor subpopulations: antipsychotic and antidopaminergic properties of metoclopramide [proceedings].
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001665:Binding Sites / Q000187:drug effects; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D017981:Receptors, Neurotransmitter / Q000187:drug effects* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy; D013134:Spiperone / Q000494:pharmacology
D011954:Receptors, Dopamine; D017981:Receptors, Neurotransmitter; D013134:Spiperone; D008787:Metoclopramide; D001058:Apomorphine